BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34719151)

  • 1. A Rare Lymphoproliferative Disease: Castleman Disease.
    Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
    Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric Plasma-Cell Type Castleman Disease Masquerading As Hodgkin Lymphoma: A Case Report.
    Ekwere TA; Eziagu UB
    J Lab Physicians; 2020 Dec; 12(3):225-229. PubMed ID: 33268942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
    Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
    Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Castleman Disease.
    Szalat R; Munshi NC
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of Castleman Disease.
    Wu D; Lim MS; Jaffe ES
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unicentric Castleman Disease.
    Wong RSM
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterogeneity of Castleman disease: report of five cases and review of the literature.
    Maslovsky I; Uriev L; Lugassy G
    Am J Med Sci; 2000 Oct; 320(4):292-5. PubMed ID: 11061358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unicentric Castleman Disease: A Rare Diagnosis of Radiological and Histological Correlation.
    Maqbool S; Javed A; Idrees T; Anwar S
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):975-978. PubMed ID: 36373120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric Castleman disease: Where are we now?
    Wang HW; Pittaluga S; Jaffe ES
    Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
    Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
    Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiofollicular lymph node hyperplasia (Castleman's disease).
    McCarty MJ; Vukelja SJ; Banks PM; Weiss RB
    Cancer Treat Rev; 1995 Jul; 21(4):291-310. PubMed ID: 7585657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases.
    Kojima M; Nakamura N; Tsukamoto N; Otuski Y; Shimizu K; Itoh H; Kobayashi S; Kobayashi H; Murase T; Masawa N; Kashimura M; Nakamura S
    Int J Surg Pathol; 2008 Oct; 16(4):391-8. PubMed ID: 18499694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castleman disease: the great mimic.
    Bonekamp D; Horton KM; Hruban RH; Fishman EK
    Radiographics; 2011 Oct; 31(6):1793-807. PubMed ID: 21997995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
    Chen H; Ba W; Chen H; Yang H
    J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical and pathological overview of Castleman disease.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
    Lurain K; Yarchoan R; Uldrick TS
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Castleman Disease.
    Abramson JS
    J Natl Compr Canc Netw; 2019 Nov; 17(11.5):1417-1419. PubMed ID: 31766018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castleman disease and TAFRO syndrome.
    Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
    Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.